+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antacids Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5735381
The antacids market size has grown steadily in recent years. It will grow from $9.16 billion in 2023 to $9.52 billion in 2024 at a compound annual growth rate (CAGR) of 3.9%. The growth observed during the historical period in the antacids market can be attributed to factors such as historical pricing and accessibility of antacid medications, shifts in dietary habits over time, economic conditions and lifestyle changes influencing healthcare choices, advancements in medical understanding and awareness of gastrointestinal conditions, and historical population demographics shaping the prevalence of acid-related issues.

The antacids market size is expected to see steady growth in the next few years. It will grow to $11 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The anticipated growth in the forecast period in the antacids market can be attributed to factors such as market competition and industry trends, evolving consumer preferences and brand loyalty, environmental considerations and lifestyle changes affecting health choices, the emergence of new health conditions, and economic conditions influencing healthcare spending. Major trends expected in the forecast period include increased health consciousness and awareness among consumers, technological advancements in antacid formulations, a preference for natural remedies, regulatory changes and compliance in the pharmaceutical industry, and a rising incidence of digestive disorders contributing to the demand for antacid medications.

The growth of the antacids market is significantly influenced by poor lifestyle choices, leading to a higher prevalence of acidity. Unhealthy lifestyle practices, such as sedentary jobs, inadequate sleep quality, and irregular dietary habits, contribute to elevated stomach acidity levels, resulting in conditions such as gastroesophageal reflux disease (GERD). The American College of Gastroenterology reports that approximately 60 million Americans suffer from GERD, fueling the demand for antacids.

The anticipated increase in the prevalence of inflammatory bowel disease is expected to drive the growth of the animal growth promoters and performance enhancers market. Inflammatory bowel disease (IBD) encompasses a group of conditions characterized by chronic inflammation in the digestive tract. Antacids, designed to regulate stomach acid levels, are commonly used for managing heartburn and indigestion. According to the International Foundation for Gastrointestinal Disorders (IFFGD), it is projected that 5–10% of the global population will have irritable bowel syndrome (IBS) by 2023, affecting between 25 and 45 million people in the United States. Additionally, a survey by the American Gastroenterological Association covering 33 countries on 6 continents revealed that more than 40% of adult respondents worldwide have functional gastrointestinal disorders (FGID), impacting their quality of life and healthcare utilization. Consequently, the increasing prevalence of inflammatory bowel disease is expected to propel the growth of the animal growth promoters and performance enhancers market in the future.

The antacids market faces a major restraint in the form of side effects associated with these medications. Common side effects include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may lead to issues such as constipation, aluminum intoxication, osteomalacia, and hypophosphatemia. Additionally, when consumed with other acidic drugs, antacids may result in reduced efficacy of both drugs due to drug absorption interactions.

An emerging trend in the antacid market is the development of mouth-melting antacids. Traditionally available in tablet, liquid, and powder forms, mouth-melting antacids utilize micro-mouth melting granules that easily dissolve in the mouth. Sunpharma's 'Pepmelt' is an example of a mouth-melting instant relief antacid that combines herbal constituents with contemporary mouth-melting technology.

Major companies in the antacids market are diversifying their product offerings by introducing multiple antacid flavors to enhance market profitability. Antacid flavors refer to the various tastes available for antacid products. Wonderbelly, a US-based digestive medicine company, introduced three antacid flavors, namely Fruity Cereal (exclusive to Target stores), Strawberry Milkshake, and Watermelon Mint, in March 2023. Wonderbelly's Antacid, containing calcium carbonate as its active ingredient, distinguishes itself as a non-GMO and vegan product without talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. Developed in collaboration with gastroenterologists and pharmaceutical manufacturers, these products prioritize quality.

In the United States, manufacturers of antacids are required to comply with the Code of Federal Regulations Title 21 established by the FDA. According to these regulations, over-the-counter (OTC) antacid products in forms suitable for oral administration are deemed safe and effective only if they meet the conditions related to active ingredients specified by the FDA.

Major companies operating in the antacids market report are Walmart Equate LLC, Private Label, Pfizer Inc., Johnson & Johnson Services Inc., Procter & Gamble Co., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc. North America was the largest region in the antacids market in 2023. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the antacids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The primary classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton pump inhibitors significantly and for an extended period reduce stomach acid production by irreversibly blocking the H+/K+ ATPase proton pump in the stomach. Antacids come in various formulations, including tablets, liquids, powders, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies, and other outlets.

The antacids market research report is one of a series of new reports that provides antacids market statistics, including antacids industry global market size, regional shares, competitors with an antacids market share, detailed antacids market segments, market trends, and opportunities, and any further data you may need to thrive in the antacids industry. This antacids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antacids market consists of sales of Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary2. Antacids Market Characteristics3. Antacids Market Trends and Strategies
4. Antacids Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Antacids Market Size and Growth
5.1. Global Antacids Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Antacids Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Antacids Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Antacids Market Segmentation
6.1. Global Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-Motility Agents
6.2. Global Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tablet
  • Liquid
  • Powder
  • Other Formulation Types
6.3. Global Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
7. Antacids Market Regional and Country Analysis
7.1. Global Antacids Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Antacids Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Antacids Market
8.1. Asia-Pacific Antacids Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Antacids Market
9.1. China Antacids Market Overview
9.2. China Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Antacids Market
10.1. India Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Antacids Market
11.1. Japan Antacids Market Overview
11.2. Japan Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Antacids Market
12.1. Australia Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Antacids Market
13.1. Indonesia Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Antacids Market
14.1. South Korea Antacids Market Overview
14.2. South Korea Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Antacids Market
15.1. Western Europe Antacids Market Overview
15.2. Western Europe Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Antacids Market
16.1. UK Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Antacids Market
17.1. Germany Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Antacids Market
18.1. France Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Antacids Market
19.1. Italy Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Antacids Market
20.1. Spain Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Antacids Market
21.1. Eastern Europe Antacids Market Overview
21.2. Eastern Europe Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Antacids Market
22.1. Russia Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Antacids Market
23.1. North America Antacids Market Overview
23.2. North America Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Antacids Market
24.1. USA Antacids Market Overview
24.2. USA Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Antacids Market
25.1. Canada Antacids Market Overview
25.2. Canada Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Antacids Market
26.1. South America Antacids Market Overview
26.2. South America Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Antacids Market
27.1. Brazil Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Antacids Market
28.1. Middle East Antacids Market Overview
28.2. Middle East Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Antacids Market
29.1. Africa Antacids Market Overview
29.2. Africa Antacids Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Antacids Market, Segmentation by Formulation Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Antacids Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Antacids Market Competitive Landscape and Company Profiles
30.1. Antacids Market Competitive Landscape
30.2. Antacids Market Company Profiles
30.2.1. Walmart Equate LLC
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Private Label
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Pfizer Inc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Johnson & Johnson Services Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Procter & Gamble Co.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Antacids Market Other Major and Innovative Companies
31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi S.A.
31.4. Bristol Myers Squibb Company
31.5. AstraZeneca plc
31.6. Abbott Laboratories
31.7. GlaxoSmithKline plc
31.8. Takeda Pharmaceutical Company Limited
31.9. Boehringer Ingelheim GmbH
31.10. Reckitt Benckiser Group plc
31.11. WellSpring Pharmaceutical Corporation
31.12. Xiuzheng Pharmaceutical Group Company Limited
31.13. Bausch Health Companies Inc.
31.14. Sun Pharmaceuticals Industries Ltd.
31.15. Dr. Reddy's Laboratories Ltd
32. Global Antacids Market Competitive Benchmarking33. Global Antacids Market Competitive Dashboard34. Key Mergers and Acquisitions in the Antacids Market
35. Antacids Market Future Outlook and Potential Analysis
35.1 Antacids Market in 2028 - Countries Offering Most New Opportunities
35.2 Antacids Market in 2028 - Segments Offering Most New Opportunities
35.3 Antacids Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Antacids Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antacids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for antacids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
2) By Formulation Type: Tablet; Liquid; Powder; Other Formulation Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

Key Companies Mentioned: Walmart Equate LLC; Private Label; Pfizer Inc; Johnson & Johnson Services Inc.; Procter & Gamble Co.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Walmart Equate LLC
  • Private Label
  • Pfizer Inc
  • Johnson & Johnson Services Inc.
  • Procter & Gamble Co.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim GmbH
  • Reckitt Benckiser Group plc
  • WellSpring Pharmaceutical Corporation
  • Xiuzheng Pharmaceutical Group Company Limited
  • Bausch Health Companies Inc.
  • Sun Pharmaceuticals Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Hikma Pharmaceuticals plc
  • Alkem Laboratories Ltd.
  • Conba Group Co. Ltd.
  • Chattem Chemicals Inc.
  • China Resources Sanjiu Medical & Pharmaceutical Co. Ltd.
  • Thornton and Ross Ltd.
  • McNeil Consumer Pharmaceuticals Co.
  • Advance Pharmaceutical Inc.

Methodology

Loading
LOADING...

Table Information